{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:14:32Z","timestamp":1791486872691,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clml.2020.12.015","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T02:05:46Z","timestamp":1609293946000},"page":"e464-e469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria"],"prefix":"10.1016","volume":"21","author":[{"given":"Andrew","family":"Fairchild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-9053","authenticated-orcid":false,"given":"Chad M.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofik","family":"Oyekunle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-0450","authenticated-orcid":false,"given":"Donna","family":"Niedzwiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1879-7463","authenticated-orcid":false,"given":"Colin","family":"Champ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris R.","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.12.015_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Rev 4th ed","first-page":"314","article-title":"Primary mediastinal (thymic) large B-cell lymphoma","author":"Gaulard","year":"2017"},{"key":"10.1016\/j.clml.2020.12.015_bib2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.12.015_bib4","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2018.36.15_suppl.7574","article-title":"Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6XR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: results of the 2X2 randomized UNFOLDER trial DSHNHL\/GLA","volume":"36","author":"Pfreundschuh","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.015_bib5","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2013.51.4505","article-title":"Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma","volume":"32","author":"Held","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.015_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A\u00a0predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.12.015_bib7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.12.015_bib8","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2020.12.015_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.12.015_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.hoc.2016.07.006","article-title":"Gray zone lymphoma: current diagnosis and treatment options","volume":"30","author":"Pilichowska","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clml.2020.12.015_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.015_bib12","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2002-05-1548","article-title":"Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages","volume":"101","author":"von Wasielewski","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.015_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3109\/10428194.2011.573032","article-title":"Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma","volume":"52","author":"De Mello","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.12.015_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2559.2004.01969.x","article-title":"CD23 expression in mediastinal large B-cell lymphomas","volume":"45","author":"Calaminici","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2020.12.015_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000478-200110000-00008","article-title":"Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib16","first-page":"735","article-title":"Discordant expression of immunoglobulin and its associated molecule mb-1\/CD79a is frequently found in mediastinal large B cell lymphomas","volume":"146","author":"Kanavaros","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d\u2019Etude des Lymphomes de l\u2019Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1309\/AJCP3Q1DHWKCQRWY","article-title":"Surface light chain expression in primary mediastinal large B-cell lymphomas by multiparameter flow cytometry","volume":"144","author":"Weinberg","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/0284186X.2020.1744718","article-title":"Presentation and management of primary mediastinal large B-cell lymphoma: a retrospective cohort analysis","volume":"59","author":"Eule","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clml.2020.12.015_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/112.2.241","article-title":"CD30 expression is common in mediastinal large B-cell lymphoma","volume":"112","author":"Higgins","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib21","doi-asserted-by":"crossref","first-page":"E436","DOI":"10.1002\/ajh.24485","article-title":"The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome","volume":"91","author":"Bledsoe","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.12.015_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1066896909331994","article-title":"The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma","volume":"18","author":"Salama","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","article-title":"Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers","volume":"25","author":"Dorfman","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cyto.b.21544","article-title":"Evaluation of primary mediastinal large B cell lymphoma by flow cytometry","volume":"94","author":"Cherian","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.clml.2020.12.015_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1066896916635816","article-title":"Mediastinal gray zone lymphoma: a wider category than we think?","volume":"24","author":"Verma","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.clml.2020.12.015_bib26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","article-title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","volume":"101","author":"Perry","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.12.015_bib27","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.015_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/bjh.15051","article-title":"R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis","volume":"180","author":"Shah","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.12.015_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijrobp.2015.02.006","article-title":"Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2020.12.015_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.14951","article-title":"Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R","volume":"179","author":"Giulino-Roth","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.12.015_bib31","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1002\/cam4.2347","article-title":"Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma","volume":"8","author":"Chan","year":"2019","journal-title":"Cancer Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020310363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020310363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:56Z","timestamp":1761870956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020310363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2152265020310363"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.12.015","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}